Results 131 to 140 of about 113,440 (299)

5700The delayed recovery of absolute lymphocyte count after induction therapy predicts cytomegalovirus viremia in heart transplantation [PDF]

, 2017
Minho Yoon, Jaewon Oh, I.C. Kim, Seok‐Min Kang   +3 more
openalex   +1 more source

Crimean‐Congo Haemorrhagic Fever Virus Exposure in Horses and Donkeys in Border Livestock Markets of Nigeria

Zoonoses and Public Health, EarlyView.
ABSTRACT Introduction Crimean‐Congo haemorrhagic fever virus (CCHFV) is a tick‐borne zoonotic pathogen of major public health importance in Africa. Although CCHFV exposure has been reported in several livestock species in Nigeria, data on equids remain limited despite their extensive involvement in livestock movement and trade.
David O. Ehizibolo, Olumuyiwa Oyekan, Nicodemus Mkpuma, Habibu Haliru, Ibrahim Garba, Isa Z. Turaki, Samdi Kennedy, Joshua M. Shallangwa, Caleb S. Kilyobas, Abdullahi Mohammed, Musa A. Muhammad, Mansur Abubakar, Maryam Muhammad, Corrie Brown, Bonto Faburay   +14 more
wiley   +1 more source

195 Hepatitis C Virus-Specific Immune Response Among Egyptian Healthcare Workers at High Risk of Infection Without Viremia or Seroconversion* [PDF]

, 2011
Sayed F. Abdelwahab, Eman Rewisha, Maha Sobhy, Iman Galal, Zainab Zakaria, Mohamed A. Mahmoud, Stefania Capone, Antonella Folgori, Mohamed Hashem, Samer S. El‐Kamary, G. Thomas Strickland, Riccardo Cortese, A Nicosia   +12 more
openalex   +1 more source

A Framework for Emergency Department–Integrated Hepatitis C Test‐and‐Treat in the United States

Journal of Viral Hepatitis, Volume 33, Issue 6, June 2026.
ABSTRACT Despite the availability of curative, direct‐acting antiviral therapy, hepatitis C virus elimination remains incomplete. Losses across the care cascade continue to limit impact, from initial diagnosis to sustained virologic response. Fewer than 1/3 of individuals ultimately achieve cure. These gaps reflect a delivery system that does not align
Saeed S. Graham
wiley   +1 more source

Low‐Barrier Fibrosis Screening in Hepatitis C Treatment: The Decompensated Cirrhosis in Hepatitis C Evaluation Questionnaire

Journal of Viral Hepatitis, Volume 33, Issue 6, June 2026.
ABSTRACT Achieving hepatitis C virus (HCV) elimination requires innovative paradigms that overcome barriers to treatment, such as requiring pre‐treatment elastography or phlebotomy‐based fibrosis assessment. To identify patients at low risk of advanced fibrosis or decompensated cirrhosis within our HCV treatment programme, we developed and ...
Hunter Spencer, Barbara Brumbach, Anna Geduldig, Lisa Nelson, Andrew Seaman   +4 more
wiley   +1 more source

PD-1 signaling promotes control of chronic viral infection by restricting type-I-interferon-mediated tissue damage [PDF]

, 2019
Immune responses are essential for pathogen elimination but also cause tissue damage, leading to disease or death. However, it is unclear how the host immune system balances control of infection and protection from the collateral tissue damage.
Egawa, Takeshi, Raju, Saravanan, Verbaro, Daniel J   +2 more
core   +1 more source

Emergency Department Opt‐Out Testing for Hepatitis B: A Two‐Year UK Multicentre Evaluation of Outcomes Across Seven Sites

Liver International, Volume 46, Issue 6, June 2026.
ABSTRACT Background and Aims An estimated 270 000 people in the UK live with hepatitis B infection, the leading global cause of liver cancer. In 2022, opt‐out hepatitis B testing was introduced in emergency departments (ED) in London. We conducted a 2‐year multicentre evaluation of this programme across seven sites.
Jennifer J. Plunkett, Basil Ahmad, Amy Teague, Tanzina Haque, Stephanie Paget, Jennifer Hart, Maximillian Habibi, Jonathan Durban, Shiny Jaimes, Sally Thomas, Helen Boothman, Supa Chantschool, Philippa C. Matthews, Rachel Hill‐Tout, Daniel Forton, Douglas Macdonald   +15 more
wiley   +1 more source

Phylogenetic analysis of spring viremia of carp virus (SVCV) identified in Poland [PDF]

, 2018
Joanna Maj‐Paluch, Ewa Borzym, Marek Matras, Magdalena Stachnik, M. Reichert   +4 more
openalex   +1 more source

Bocavirus viremia

Annals of Thoracic Medicine, 2015
Pathoom Sukkaromdee, Viroj Wiwanitkit
openaire   +3 more sources

Advancing Maternal Health with Long‐Acting Therapeutics: Priorities, Efficacy and Safety Considerations, and Emerging Technologies

Clinical Pharmacology &Therapeutics, Volume 119, Issue 5, Page 1179-1194, May 2026.
Maternal health remains a critical global concern, particularly in underserved populations and in low‐ and middle‐income countries where access to safe and effective therapeutics is limited. Despite the use of medications by most women during pregnancy, the exclusion of pregnant and lactating women from clinical trials has resulted in significant data ...
Rachel K. Scott, Sharon Nachman, Ethel D. Weld, Rachel Daley, Shakir Atoyebi, Robert Bies, Catriona Waitt, Adeniyi Olagunju   +7 more
wiley   +1 more source